Ceclazepide
Ceclazepide (TR2-A), a CCK2R antagonist, is an orally active Mycobacterium abscessus inhibitor. Ceclazepide inhibits acid secretion in rats. Ceclazepide effectively suppresses the growth of M. abscessus wild-type strain and multiple subspecies. Ceclazepide inhibits M. abscessus growth within macrophages without causing harm[1][2].
Product Specifications
CAS Number
[1801749-44-9]
Product Name Alternative
TR2-A
UNSPSC
12352005
Target
Bacterial; Cholecystokinin Receptor
Related Pathways
Anti-infection; GPCR/G Protein; Neuronal Signaling
Field of Research
Infection; Cardiovascular Disease
Smiles
CC(OCC(C)(C)C(CN1C2=CC=CC=C2C(C3=CC=CC=N3)=N[C@H](C1=O)NC(NC4=CC(NC)=CC=C4)=O)=O)=O
Molecular Formula
C30H32N6O5
Molecular Weight
556.61
References & Citations
[1]K.L. Therese, et al. Ceclazepide as novel Mycobacterium abscessus inhibitor. bioRxiv. April 03, 2024.|[2]Chen D, et al. Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacology. J Neuroendocrinol. 2023 Nov;35 (11) :e13305.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
